Dama, Azzubayn A.
HRN: 21-45-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFTRIAXONE 1G (VIAL)
06/08/2022
06/15/2022
IV DRIP
165mg
Q12
Abscess Right Mastoid; T/c Sepsis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Eye, Ear, Nose, Throat, & MouthUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes